Literature DB >> 8999602

[Is there a superantigen effect on steroid-responsive meningitis-arteritis in dogs?].

A Tipold1, R Somberg, P Felsburg.   

Abstract

Steroid responsive meningitis-arthritis in the dog is a frequently occurring disease in small animal practice. However, the etiology and pathogenesis are unknown. Immunopathologic events are suspected, since IgA seems to play a central role in pathogenesis. The influence of an infectious agent is possible. To classify the nature of such an agent, we tried to find in this study an oligoclonal T-cell proliferation using Southern blot technique. This could give a hint for an infection with a superantigen. In a first step a proliferation assay was performed, proving that staphylococcus enterotoxins A and B induce a strong lymphocyte proliferation in the dog in vitro. In one out of six dogs with steroid responsive meningitis-arthritis T-cell receptor rearrangement was detected after digestion of genomic DNA with two different restriction enzymes. Therefore a superantigen influence in this specific disease seems to be possible, but could not be proven finally using Southern blot techniques.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8999602

Source DB:  PubMed          Journal:  Tierarztl Prax        ISSN: 0303-6286


  2 in total

1.  A retrospective epidemiological study of clinical signs and familial predisposition associated with aseptic meningitis in the Norwegian population of Nova Scotia duck tolling retrievers born 1994-2003.

Authors:  Kristin P Anfinsen; Mette Berendt; Flora J H Liste; Therese R Haagensen; Astrid Indrebo; Frode Lingaas; Oyvind Stigen; Lis Alban
Journal:  Can J Vet Res       Date:  2008-07       Impact factor: 1.310

2.  Toll-like receptors 4 and 9 are responsible for the maintenance of the inflammatory reaction in canine steroid-responsive meningitis-arteritis, a large animal model for neutrophilic meningitis.

Authors:  Arianna Maiolini; Regina Carlson; Andrea Tipold
Journal:  J Neuroinflammation       Date:  2012-09-27       Impact factor: 8.322

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.